Suprefact Depot

Country: Նոր Զելանդիա

language: անգլերեն

source: Medsafe (Medicines Safety Authority)

active_ingredient:

Buserelin acetate 9.9mg equivalent to 9.45 mg of buserelin

MAH:

sanofi-aventis new zealand limited

INN:

Buserelin acetate 9.9 mg (equivalent to 9.45 mg of buserelin)

dosage:

9.45 mg

pharmaceutical_form:

Subcutaneous implant

composition:

Active: Buserelin acetate 9.9mg equivalent to 9.45 mg of buserelin Excipient: Polyglactin

units_in_package:

Bag, plastic, trilaminate, 1 implant

class:

Prescription

prescription_type:

Prescription

manufactured_by:

Sanofi-Aventis Deutschland GmbH

leaflet_short:

Package - Contents - Shelf Life: Bag, plastic, trilaminate - 1 implants - 3 years from date of manufacture stored at or below 30°C

authorization_date:

1998-10-22